Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switch.

@article{Tomasoni2003PredictorsOL,
  title={Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switch.},
  author={Lina Rachele Tomasoni and Andrea Patroni and Carol Torti and Giuseppe Paraninfo and Franco Gargiulo and Eugenia Quir{\'o}s-Rold{\'a}n and Maria Cristina Uccelli and Paolo Air{\'o} and Carmine Tinelli and Giampiero Carosi and F Castelli},
  journal={HIV clinical trials},
  year={2003},
  volume={4 5},
  pages={311-23}
}
OBJECTIVE To assess predictive factors of long-term immune restoration in patients who started protease inhibitor (PI)-based HAART and experienced virological rebound after initial complete success. METHOD A retrospective longitudinal analysis of all HIV-infected patients who started their first PI-based HAART and reached viral load below 500 copies/mL was carried out in a large academic center in Italy. Patients were classified either as complete virologic responder (CR) or rebounders (REB… CONTINUE READING